Biomedical Innovation Program


The Biomedical Innovation Program (BIP) at OHSU accelerates the delivery of healthcare technologies from academia to the marketplace in order to improve human health. The program supports collaborative translational research that will lead to technology commercialization.

The BIP cultivates, evaluates, and funds promising translational projects with the objective of moving innovative technologies to clinical application through commercialization. Do you have an idea for a technical innovation to improve patient care?

OCTRI BIP Program Image


Track 1: Device, diagnostics, and software development

  • Deadline: Closed. Please check back in August 2019.
  • Amount: Up to $40,000
  • Eligibility: Principal Investigators must meet the OHSU eligibility requirements

Track 2: Drug discovery and therapeutics development

This funding opportunity, an extension of the Biomedical Innovation Program, is intended for drug discovery platforms and therapeutic technology projects. Examples of responsive application topics include but are not limited to development and validation of drug targets, screening platforms, small molecules, antibodies, vaccines, and biologics. Through this funding mechanism, OCTRI and TTBD intend to support and accelerate creative, interdisciplinary drug discovery and therapeutic development research at OHSU. Project budgets should not exceed $60,000. Projects will typically be supported for a one-year period; predetermined milestones and quantitative metrics of success will be evaluated on a regular basis.

  • Deadline: Full applications due by April 23rd, 2019.
  • Amount: Up to $60,000
  • Eligibility: Principal investigators must meet OHSU eligibility requirements

The 2019 BIP Drug Discovery RFA has details about the submission process, eligibility, and application instructions.



Registration open for Fall 2018! A 4-week biomedical innovation and commercialization course designed for the busy biomedical researcher and clinician. Through this course you will learn the basic components of biomedical commercialization and build a competitive business case for funding and partnership development.

Visit the fastPACE webpage to learn more, including if this course is right for you, how to register, and who to contact.


INVENT is an education program for innovation and entrepreneurship in the health and life sciences, hosted by the OHSU Division of Management and supported by OCTRI, OHSU Technology Transfer & Business Development, OHSU Department of Surgery, Knight Cardiovascular Institute Center for Developmental Health, University of Portland, Oregon Translational Research & Development Institute.

Visit the INVENT webpage to learn more about the series and to register for the free workshops and lectures.

Watch previous sessions of the INVENT lecture and seminar series here.

Program Contact

Our office is open year-round to offer guidance towards developing your idea for future award cycles, and welcomes any interested parties to contact us at any time. Read more about the program here.

Aditi Martin, Ph.D.
Oregon Clinical and Translational Research Institute
Program Director, Pilot Awards

Jonathan Jubera
Oregon Clinical and Translational Research Institute
Biomedical Innovation Program, Project Manager